Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment, and you shouldn't expect protection if something goes wrong. Take 2 minutes to learn more

Buy Johnson & Johnson

JNJ

About JNJ

As one of the most iconic healthcare and consumer goods companies in the world, Johnson & Johnson (Stock Ticker: JNJ) is a blue-chip stock. 

Founded in 1886 as a surgical dressing supplier, Johnson & Johnson gradually invested in other medical and healthcare companies, including prescription drugs, cough medicines, pharmaceuticals, and baby powder. It was listed as a public company in 1944.

Today, it has more than 130,000 employees across 250 companies, and annual revenues in 2019 of $82 billion.

As a result of the coronavirus pandemic, Johnson & Johnson has committed $1 billion towards developing a vaccine for COVID-19, in conjunction with the US government (enacted through a non-profit vehicle).

JNJ stock price

JNJ has a market capitalization of $390.61 billion with 2.63 billion shares in circulation. Revenues have grown by approximately 250% in the past ten years and shares have risen in price, thanks to good management and increasing demand for the company’s range of products and services.

What the bears are saying

  • Lawsuits could pose a risk: In an increasingly litigious world, healthcare companies like Johnson & Johnson face constant threats, with defense and settlement becoming extraordinarily expensive.
  • Strong competition: Johnson & Johnson are up against successful, hugely profitable companies like Procter & Gamble, Pfizer, Unilever, Reckitt Benckiser, Colgate Palmolive, and more. 
  • One bad lawsuit can hit profits materially: Losing one big class action could affect the company’s share price and erode the annual dividend. 

What the bulls are saying

  • JNJ stock is good for dividends: Johnson & Johnson provides a consistent dividend yield of between 2% and 3% p.a.
  • Healthcare is in demand and JNJ is diverse and robust: Due to Johnson & Johnson’s investments in a wide range of healthcare and consumer products companies, JNJ Stock is likely to enjoy continued strong growth in the future.
  • The company is over 130 years old: You don’t stay in business and have an $80+ billion annual turnover without doing things well. JNJ has a bright future.

How to invest in Johnson & Johnson (JNJ Stock) with Uphold

With Uphold, it's easy to invest in JNJ stock. Using our simple interface, you can buy shares, foreign currencies, precious metals, and stablecoins in seconds. 

Here’s how fast it is to get started:

  1. Go to Uphold.com and click ‘Sign up’.
  2. Enter your email address, create a password, and complete a 2-minute identity check.  
  3. Your account will be created instantly and you can start using Uphold.

You can fund your account to buy JNJ shares with your debit card, credit card, bank account, or crypto deposit. Your Uphold account can also be used to make payments to vendors, and send money to friends on the other side of the world, and more.

Uphold’s ‘Anything-to-Anything’ trading experience will make any currency exchange a seamless, commission-free process.

Open an Uphold account

*U.S. stock trading is not available in the U.S., U.K., and certain other jurisdictions.

This article is for informational purposes only and takes no account of particular personal or market circumstances, and should not be relied upon as investment, tax, or legal advice. For investment, tax, or legal advice, and before taking any action you should consult your own advisors. Note that assets such as equities present unique risks for investors.

This content is correct as of October 2020

Get more coin for your coin

0% withdrawal fees

Low spreads

Learn more


Uphold Europe Limited, Reg No. 09281410, Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, United Kingdom, W1W 8DH

Uphold (FRN: 938277) is registered with the Financial Conduct Authority (FCA) for AML purposes and complies with the Money Laundering, Terrorist Financing and Transfer for Funds (Information on the Payer).

Uphold is also an EMD agent (FRN: 938277) of Optimus Cards UK Limited (FRN: 902034) which is authorised and regulated by the Financial Conduct Authority to issue e-money pursuant to the Electronic Money Regulations 2011.

Cryptoasset services offered by Uphold Europe Limited are unregulated and not covered by the Financial Services Compensation Scheme as well as the FCA’s consumer protection regulations. Cryptoassets are very high risk and speculative. You should be aware and prepared to potentially lose some or all of your money. You should carefully consider whether trading or holding cryptoassets is suitable for you in light of your financial circumstances. Gains may be subject to Capital Gains Tax and there may be extra charges when paying via credit card from your provider. Geographic restrictions may apply.

Fiat money payments and balances (fiat is another name for traditional currencies, such as GBP, USD and EUR) constitute regulated e-money and payment services. In providing fiat balances, you are being issued with e-money by Optimus and Uphold is acting as its agent. See specific e-money terms. E-money is not a deposit or investment account which means that your e-money will not be protected by the FSCS. Your funds will be held in a designated safeguarding account with a regulated financial institution. E-money will not earn any interest.

Uphold is certified for SOC 2 Type 2, ISO 27001, and PCI DSS, ensuring rigorous control over our information security management systems, data handling, and payment processing practices. Furthermore, we comply with the General Data Protection Regulation (GDPR), California Consumer Privacy Act (CCPA), and the UK Data Protection Act, underscoring our dedication to protecting the personal data and privacy rights of our global customers.

© 2026 Uphold Europe Limited. All rights reserved.